A FIVE-YEAR ASSESSMENT OF PATIENTS IN A CONTROLLED TRIAL OF STREPTOMYCIN, PARA-AMINOSALICYLIC ACID, AND STREPTOMYCIN PLUS PARA-AMINOSALICYLIC ACID, IN PULMONARY TUBERCULOSIS1Report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council

Sign in / Sign up

Export Citation Format

Share Document